Benzinga | Jan 7, 2021 08:03AM EST

Neuronetics Announces Expansion Of Sales Organization

MALVERN, Pa., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced the expansion of its commercial organization.



Sales Organization Update

As part of the Company's previously announced sales organization optimization initiative, the Company recently expanded the size of its sales organization, including the addition of:

* Thirteen new Business Development Managers ("BDMs"), bringing the total number of BDMs to 22

* Nine new NeuroStar Practice Consultants ("NPCs"), bringing the total number of NPCs to 27

In addition, the Company added personnel to its sales management, reimbursement, clinical training and marketing functions.

"We are delighted with the exceptional talent we were able to attract to Neuronetics. Many of these individuals have extensive experience with the capital sale with a trailing treatment session model. And, these individuals share the core values needed to drive the execution of our strategy and company mission," said Keith J. Sullivan, President and Chief Executive Officer of Neuronetics. "We are very excited about what the future holds at Neuronetics and look forward to leveraging the momentum we have built to continue to expand awareness and access to NeuroStar Advanced Therapy for people who are suffering from depression."